Skip to main content
DFTX logo
DFTX
(NASDAQ)
Definium Therapeutics, Inc.
$44.91-- (--)
Loading... - Market loading

Definium Therapeutics, Inc. (DFTX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Definium Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(10 total ratings in last 90 days)
Medium Confidence:1 Buy/Sell

Average Price Target

$61.50
36.94% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest DFTX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Paul Matteis
Stifel Nicolaus
BuyReiterates
$30.00 $60.00
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$60.00 $58.00
Francois Brisebois
LifeSci Capital
BuyMaintains
$44.00 $63.00
Michael Okunewitch
Maxim
BuyReiterates
$40.00 $50.00
Justin Walsh
JonesTrading
BuyReiterates
$61.00 $74.00
Christopher Chen
Baird
BuyMaintains
$37.00 $57.00
Patrick Trucchio
HC Wainwright
BuyReiterates
$70.00
Jay Olson
Oppenheimer
BuyMaintains
$40.00 $60.00
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$38.00
Francois Brisebois
LifeSci Capital
BuyReiterates
$38.00 $44.00

Frequently Asked Questions

What is the analyst consensus rating for DFTX?

The analyst consensus rating for DFTX is "Buy" based on 8 analyst recommendations.

What is the average price target for DFTX?

The average 12-month price target for DFTX is $61.50, representing an upside of 36.9% from the current price of $44.91.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.